Unknown

Dataset Information

0

High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer.


ABSTRACT: The aim of the study to evaluate the prognostic significance of vascular endothelial growth factor receptor 1 and 2 (VEGFR1/2) expression levels and to correlate these levels with clinicopathological parameters in patients with cervical cancer.Forty-two patients with International Federation of Gynecology and Obstetrics Stage IIB-IVB cervical cancer were analyzed between January 2011 and December 2012. RNA expression levels of VEGFR1/2 were assessed by branched DNA-liquidchip technology and immunohistochemistry. Associations between RNA expression levels, important clinicopathological parameters, and patient survival were statistically evaluated.Higher VEGFR1/2 expression levels were predictive of poor overall survival (P?=?0.009 and P?=?0.024, respectively). Patients with higher VEGFR1 expression levels were associated with poorer progression-free survival than those with lower VEGFR1 expression levels (P?=?0.043). In addition, patients with higher VEGFR1 expression levels were more likely to develop distant metastases than those with lower VEGFR1 expression levels (P?=?0.049). Higher VEGFR2 expression levels were associated with larger tumor size (P?=?0.037).VEGFR1/2 expression levels were prognostic factors for patients with cervical cancer. Higher VEGFR1/2 expression levels were also predictive of poor overall survival.

SUBMITTER: Dang YZ 

PROVIDER: S-EPMC5228683 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer.

Dang Yun-Zhi YZ   Zhang Ying Y   Li Jian-Ping JP   Hu Jing J   Li Wei-Wei WW   Li Pei P   Wei Li-Chun LC   Shi Mei M  

Medicine 20170101 1


The aim of the study to evaluate the prognostic significance of vascular endothelial growth factor receptor 1 and 2 (VEGFR1/2) expression levels and to correlate these levels with clinicopathological parameters in patients with cervical cancer.Forty-two patients with International Federation of Gynecology and Obstetrics Stage IIB-IVB cervical cancer were analyzed between January 2011 and December 2012. RNA expression levels of VEGFR1/2 were assessed by branched DNA-liquidchip technology and immu  ...[more]

Similar Datasets

| S-EPMC6256838 | biostudies-literature
| S-EPMC9508458 | biostudies-literature
| S-EPMC7086256 | biostudies-literature
| S-EPMC8593198 | biostudies-literature
| S-EPMC4228363 | biostudies-literature
| S-EPMC9634091 | biostudies-literature
| S-EPMC6510714 | biostudies-literature
| S-EPMC5661598 | biostudies-literature
| S-EPMC6179236 | biostudies-literature
| S-EPMC9271802 | biostudies-literature